About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half ...
Most adults (62%) say they have taken a GLP-1 drug to treat a chronic condition including diabetes or heart disease, while 43 ...
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, ...
GLP-1s have exploded in popularity, to the where, a ccording to the Kaiser Family Foundation, 12% of adults has taken Ozempic ...
Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a ...
Agents in development would preserve lean body mass and further promote fat loss in people taking new antiobesity medications ...
"Does your insurance cover anti-obesity drugs?" Laura Davisson, MD, once again asked the patient before her. She said these cost-of-care conversations are now a daily occurrence. While glucagon-like ...
A NEW weight loss drug could hijack the brain like a ‘Trojan horse’ to double weight loss. The drug could help the body to ...
Nestlé has created a new frozen food line, aimed at people taking GLP-1 medications. Experts say maintaining a healthy diet ...
For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023.
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people taking GLP-1 drugs for weight loss.
Drug Stocks latest news, photos, videos, breaking news, special reports, blogs, and updates from Business Insider India ...